Phase 1b Study of PLX5622 in Rheumatoid Arthritis Patients Who Are Receiving Methotrexate
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
PLX115-02 is a phase 1b study to assess how the study drug, PLX5622: 1. affects the body, 2.
how the body affects PLX5622 3. the interaction of PLX5622 with Methotrexate and 4. the
safety of PLX5622 in rheumatoid arthritis patients taking Methotrexate